Stock 4502 TAKEDA PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-09 am EDT 		5-day change 1st Jan Change
4,070 JPY +0.42% Intraday chart for Takeda Pharmaceutical Company Limited -1.33% +0.39%
03:21pm Sector Update: Health Care Stocks Steady Pre-Bell Thursday MT
10:33am Takeda Pharmaceutical's Fiscal Q1 Core Earnings Decline, Revenue Increases; Fiscal 2024 Outlook Issued MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Steady Pre-Bell Thursday
MT
Takeda Pharmaceutical : FINANCIAL APPENDIX - Form 6-K
PU
Takeda Pharmaceutical's Fiscal Q1 Core Earnings Decline, Revenue Increases; Fiscal 2024 Outlook Issued
MT
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss -- Update
DJ
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
DJ
Japan's Takeda Pharma says full-year profit slumps 56%
RE
Takeda Pharmaceutical Company Limited Announces Demise of its Board Member, Olivier Bohuon
CI
Takeda Pharmaceutical : FY2023 (April 2023-March 2024) Quarter 4 Presentation
PU
Takeda Pharmaceutical : FY2023 (April 2023-March 2024) Quarter 4 Quarterly Financial Report
PU
Takeda Pharmaceutical : FY2023 (April 2023-March 2024) Quarter 4 Quarterly Highlights Infographic
PU
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
BU
Takeda Pharmaceutical Company Limited Provides Earnings Guidance for the Full Year of 2024
CI
Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement
EQ
Takeda Pharmaceutical Company Limited Declares Dividend for the Year Ended March 31, 2024, Payable June 27, 2024; Provides Dividend Guidance for the Second Quarter-End and Year-End of Fiscal Year Ending March 31, 2025
CI
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
RE
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
AQ
EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug
MT
Hutchmed notes CHMP's positive opinion for fruiquintinib approval
AN
European Medicines Agency Committee Backs Approval of Takeda's Fruquintinib to Treat Colorectal Cancer
MT
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. News Takeda Pharmaceutical Company Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW